Thursday, January 25, 2018 6:46:19 PM
Abgenix (bought out by Amgen
Sonofi
Biotest
Bayer
Novartis
Eli Lilly
Roche
Here's the link to bio of the old CEO you were mentioning. Business experience but no industry experience.
.https://www.bloomberg.com/research/stocks/people/person.asp?personId=182588&privcapId=29794
Have a look at their new CEO and management now. Changed a little since then and seems quite experienced.
http://www.immunogen.com/about-us/executive-officers
Funny how the new CEO took over April 26th 2016. Have a look at their price then. They were on a serious downward trend from $18. Aug of 2016 were down to under $3. But now they are above $8.
Again just goes back to my point of getting experience into this company to help us get to the next level. Others do it such as the one above, same with Sangamo. Funny they did it in the same year as well, 2016. They were sitting at $6 range then, $20 now. But I will just continue to shake my head in disbelief of people not wanting this for a company they invest in.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM